Inflammatory activation following interruption of long-term cardiac resynchronization therapy

Heart and Vessels

Volumn 28, Issue 5, 2013, Pages 583-588

  Rubaj, Andrzej ^a   Ruciński, Piotr ^a   Oleszczak, Krzysztof ^a   Trojnar, Michał K ^a   Wójcik, Maciej ^a   Wysokiński, Andrzej ^a   Kutarski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

C reactive protein; Cardiac resynchronization therapy; Heart failure; Interleukin 6; Neopterin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 6; NEOPTERIN;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RESPONSE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FORWARD HEART FAILURE; HEART FAILURE; HUMAN; HUMAN CELL; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; NEOPTERIN; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 84884672452     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0285-y     Document Type: Article

References (32)

1. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH (2007) Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297:2502-2514
2. Rossi A, Rossi G, Piacenti M, Startari U, Panchetti L, Morales MA (2008) The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Heart Vessels 23:217-223
3. Donal E, Leclercq C, Linde C, Daubert JC (2006) Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 27:1018-1025
4. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201-1206
5. Wang Y, Zhou Y, Meng L, Lu X, Ou N, Li X (2009) Inflammatory mediators in Chinese patients with congestive heart failure. J Clin Pharmacol 49:591-599
6. Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C (2007) Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 121:68-73
7. Lappegard KT, Bjornstad H (2006) Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol 29:753-758
8. Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A, Kolokathis F, Paraskevaidis IA, Leftheriotis D, Kremastinos DT (2006) Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol 29:255-261
9. Knight BP, Desai A, Coman J, Faddis M, Yong P (2004) Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44:72-77
10. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN (2010) Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 121:1985-1991
11. Woltjer HH, Bogaard HJ, de Vries PM (1997) The technique of impedance cardiography. Eur Heart J 18:1396-1403
12. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, Lin H, Kong SL, Lam YM, Hill MR, Lau CP (2002) Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105:438-445
13. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ (2007) Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 50:2071-2077
14. Ypenburg C, Van Bommel RJ, Marsan NA, Delgado V, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ (2008) Effects of interruption of long-term cardiac resynchronization therapy on left ventricular function and dyssynchrony. Am J Cardiol 102:718-721
15. Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D (2009) Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy. Echocardiography 26:759-765
16. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278-1283
17. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655-663
18. Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, Decramer M (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111:996-1005
19. Nakagomi A, Seino Y, Endoh Y, Kusama Y, Atarashi H, Mizuno K (2010) Upregulation of monocyte proinflammatory cytokine production by C-reactive protein is significantly related to ongoing myocardial damage and future cardiac events in patients with chronic heart failure. J Card Fail 16:562-571
20. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2010) C-reactive protein and all-cause mortality - the Copenhagen City Heart Study. Eur Heart J 31:1624-1632
21. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73-76
22. Orus J, Roig E, Perez-Villa F, Pare C, Azqueta M, Filella X, Heras M, Sanz G (2000) Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 19:419-425
23. Suzuki H, Sato R, Sato T, Shoji M, Iso Y, Kondo T, Shibata M, Koba S, Katagiri T (2005) Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100:415-420
24. Jug B, Salobir BG, Vene N, Sebestjen M, Sabovic M, Keber I (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels 24:271-276
25. Trachtenberg BH, Hare JM (2009) Biomarkers of oxidative stress in heart failure. Heart Fail Clin 5:561-577
26. Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E (2011) Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 32:1390-1397
27. Kelly RA, Smith TW (1997) Cytokines and cardiac contractile function. Circulation 95:778-781
28. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241-247
29. Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C (2009) Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 47:166-172
30. Ramasubbu K, Oliveira G, Torre-Amione G (2006) Novel therapies for heart failure: focus on anti-inflammatory strategies. Congest Heart Fail 12:153-159
31. Oyama JI, Kudo Y, Maeda T, Node K, Makino N (2012) Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels. doi: 10.1007/s00380-011-0220-7
32. Miettinen KH, Lassus J, Harjola VP, Siirila-Waris K, Melin J, Punnonen KR, Nieminen MS, Laakso M, Peuhkurinen KJ (2008) Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 10:396-403